
RpoB	O
with	O
DPD	B-Supp
2	O
(	B-Technique
ChIP	I-Technique
-	I-Technique
exo	I-Technique
)	I-Technique

genotype	O
/	O
variation	O
:	O
delta-gadW	B-Gtype

Lrp_	O
NH4Cl	B-Supp
_3	O

treatment	O
:	O
glucose	B-Med
(	I-Med
2	I-Med
g/L	I-Med
)	I-Med
minimal	I-Med
M9	I-Med
medium	I-Med
supplemented	O
without	O
10	B-Supp
mM	I-Supp
leucine	I-Supp

genotype	O
:	O
gadX-8myc	B-Gtype

Wild-type	B-Gtype
Anaerobic	B-Air
A	O

Cra	O
acetate	B-Supp
2	O

culture	O
condition	O
:	O
Aerobic	B-Air
cultures	O

WT	B-Gtype
_	O
RNASeq	B-Technique

cultured	O
in	O
:	O
M9	B-Med
minimal	I-Med
media	I-Med
with	O
0.2	B-Supp
%	I-Supp
acetate	I-Supp

chip	O
antibody	O
:	O
anti-RpoS	B-Anti
(	O
neoclone	O
,	O
WP009	O
)	O

WT	B-Gtype
PQ	B-Supp
2	O

Cells	O
were	O
grown	O
at	O
37	B-Temp
°C	I-Temp
to	O
an	O
OD600	B-OD
of	I-OD
about	I-OD
0.15	I-OD
in	O
100	O
ml	O
LB	B-Med
0.2	B-Supp
%	I-Supp
glucose	I-Supp
)	O
.	O

LB	B-Med
0.4	O
B2	O
TEX	O
neg	O
L1	O
HS2	O

Δfur	B-Gtype
with	O
DPD	B-Supp
2	O
(	B-Technique
RNA	I-Technique
-seq	I-Technique
)	I-Technique

ΔgadW	B-Gtype
pH5.5	B-pH
1	O

Wild	B-Gtype
type	I-Gtype
control	O
(	O
2.5	O
min	O
)	O

genotype	O
/	O
variation	O
:	O
delta_cra	B-Gtype

genotype	O
:	O
gadE-8myc	B-Gtype

Δcra	B-Gtype
glucose	B-Supp
1	O

∆fur	B-Gtype
Anaerobic	B-Air
[	O
IP	O
vs	O
nput	O
]	O

affyexp_	O
delta-fnr	B-Gtype
_	O
glucose	B-Supp
_	O
NH4Cl	B-Supp
_	O
NO3	B-Supp
_1.CEL	O

affyexp_	O
wt	B-Gtype
_	O
glucose	B-Supp
_	O
NH4Cl	B-Supp
_	O
NO3	B-Supp
_1.CEL	O

chip	O
antibody	O
:	O
9E10	B-Anti
Myc	B-Anti
tag	I-Anti
antibody	O

genotype	O
:	O
ompR-8myc	B-Gtype

Ecoli_	O
dFNR	B-Gtype
_rep2_	O
anaerobic	B-Air

genotype	O
:	O
ompR	B-Gtype
deletion	I-Gtype
mutant	I-Gtype

treatment	O
:	O
glucose	B-Med
(	I-Med
2	I-Med
g/L	I-Med
)	I-Med
minimal	I-Med
W2	I-Med
medium	I-Med
supplemented	O
with	O
2g	B-Supp
/	I-Supp
L	I-Supp
glutamine	I-Supp

Genome_build	O
:	O
NC_000913.2	B-Gversion

growth	O
phase	O
:	O
mid-log	B-Phase
phase	I-Phase
OD600	B-OD
=	I-OD
0.3	I-OD

NsrR_Flagtag	B-Gtype
_rep1	O

M9	B-Med
minimal	I-Med
complete	I-Med
media	I-Med
,	O
cultures	O
grown	O
aerobically	B-Air
at	O
30	B-Temp
degrees	I-Temp
C	I-Temp
in	O
a	O
gyratory	B-Agit
water	I-Agit
bath	I-Agit
shaking	I-Agit
at	I-Agit
240	I-Agit
rpm	I-Agit

LB	B-Med
2.0	O
B1	O
TEX	O
neg	O
L2	O
HS2	O

Cells	O
were	O
grown	O
aerobically	O
(	O
70	O
%	O
N2	O
,	O
25	O
%	O
O2	O
,	O
and	O
5	O
%	O
CO2	O
)	O
or	O
anaerobically	B-Air
(	I-Air
95	I-Air
%	I-Air
N2	I-Air
and	I-Air
5	I-Air
%	I-Air
CO2	I-Air
)	I-Air
until	O
mid-log	B-Phase
phase	I-Phase
OD600	B-OD
of	I-OD
~0.3-0.35	I-OD
)	O
in	O
MOPS	B-Med
minimal	I-Med
glucose	I-Med
media	I-Med
containing	O
10	B-Supp
µM	I-Supp
FeSO4	I-Supp

∆fur	B-Gtype
Aerobic	B-Air
A	O

RpoB	O
with	O
Fe	B-Supp

treatment	O
:	O
glucose	B-Med
(	I-Med
2	I-Med
g/L	I-Med
)	I-Med
minimal	I-Med
M9	I-Med
medium	I-Med
supplemented	O
with	O
10	B-Supp
mM	I-Supp
leucine	I-Supp

LB	B-Med
0.4	O
B2	O
TEX	O
neg	O
L1	O
HS1	O

Escherichia	B-Orgn
coli	I-Orgn
K-12	I-Orgn

affyexp_	O
wt	B-Gtype
_	O
glucose	B-Supp
_	O
NH4Cl	B-Supp
_	O
NO3	B-Supp
_3.CEL	O

SoxR	O
PQ	B-Supp
1	O

chip-ArcA_	O
ArcA8myc	B-Gtype
_	O
glucose	B-Supp
_	O
NH4CL	B-Supp
_	O
NO3	B-Supp
_1	O

affyexp_	O
delta-arcA	B-Gtype
_	O
glucose	B-Supp
_	O
NH4Cl	B-Supp
_	O
NO3	B-Supp
_1.CEL	O

ChIP-exo	B-Technique
GadW	O
pH5.5	B-pH
2	O

Cells	O
were	O
grown	O
in	O
LB	B-Med
media	I-Med
with	O
1	B-Supp
mM	I-Supp
IPTG	I-Supp
at	O
37	B-Temp
°C	I-Temp
with	O
shaking	O
for	O
2	B-Supp
hours	I-Supp

Wild	B-Gtype
type	I-Gtype
control	O
(	O
20	O
min	O
)	O

Genome_build	O
:	O
NC_000913	B-Gversion

chip	O
antibody	O
:	O
anti-rpoB	B-Anti
(	O
Santa	O
Cruz	O
Biotech	O
,	O
sc	O
-	O
56766	O
)	O

WT	B-Gtype
_	O
ChIPSeq	B-Technique
_2	O

Sequenced	O
reads	O
were	O
mapped	O
onto	O
NC_000913	B-Gversion
reference	O
genome	O
sequence	O
using	O
bowtie	O
v1.0.0	O
with	O
parameters	O
-	O
X	O
1000	O
-n	O
2	O
-3	O
3	O
-S	O

OmpR	O
NaCl	B-Supp
1	O

PurR_	O
glucose	B-Supp
_1	O

culture	O
condition	O
:	O
nitrate	B-Supp
respiratory	O
condition	O

chip-Fnr_	O
Fnr8myc	B-Gtype
_	O
glucose	B-Supp
_	O
NH4CL	B-Supp
_	O
anaerobic	B-Air
_1	O

E.	O
coli	O
K-12	O
MG1655	O
WT	O
,	O
and	O
Δcra	O
were	O
grown	O
to	O
mid-log	B-Phase
phase	I-Phase
aerobically	B-Air
at	O
37°C	B-Temp
in	O
M9	B-Med
minimal	I-Med
media	I-Med
supplemented	O
with	O
0.2	B-Supp
%	I-Supp
glucose	O
,	O
fructose	O
and	O
acetate	O
.	O

Aerobic	B-Air
cultures	O

medium	O
:	O
LB	B-Med

Cells	O
were	O
grown	O
aerobically	O
(	O
70	O
%	O
N2	O
,	O
25	O
%	O
O2	O
,	O
and	O
5	O
%	O
CO2	O
)	O
or	O
anaerobically	B-Air
(	I-Air
95	I-Air
%	I-Air
N2	I-Air
and	I-Air
5	I-Air
%	I-Air
CO2	I-Air
)	I-Air
until	O
mid-log	B-Phase
phase	I-Phase
OD600	B-OD
of	I-OD
~0.3-0.35	I-OD
)	O
.	O

strain	O
:	O
K-12	B-Strain

σ32	O
43°C	B-Temp
rep2	O

genotype	O
/	O
variation	O
:	O
Combined	B-Gtype
input	I-Gtype

ΔoxyR	B-Gtype
PQ	B-Supp
2	O

∆ryhB	B-Gtype
Anaerobic	B-Air

ip	O
antibody	O
:	O
affinity	B-Anti
purified	I-Anti
anti-Fur	I-Anti
antibody	I-Anti

Fur	O
IP	O
ChIP-Seq	B-Technique
Anaerobic	B-Air
Iron	B-Supp
Deficient	O
B	O

WT	B-Gtype
acetate	B-Supp
1	O

Δfur	B-Gtype
with	O
Fe	B-Supp
2	O
(	B-Technique
RNA	I-Technique
-seq	I-Technique
)	I-Technique

ΔgadX	B-Gtype
pH5.5	B-pH
1	O

Escherichia	O
coli	O
MG1655	O
K-12	O
WT	O
and	O
∆fnr	O
were	O
grown	O
to	O
mid-log	B-Phase
phase	I-Phase
O.D.600nm	B-OD
0.3	I-OD
anerobically	B-Air
(	I-Air
95	I-Air
%	I-Air
N2	I-Air
,	I-Air
5	I-Air
%	I-Air
CO2	I-Air
)	I-Air
at	O
37°C	B-Temp
in	O
MOPS	B-Med
0.2	B-Supp
%	I-Supp
glucose	I-Supp
media	O
(	O
Ref	O
)	O
.	O

genotype	O
:	O
ΔseqA	B-Gtype

At	O
OD450	B-OD
=	I-OD
0.3	I-OD
,	O
cultures	O
induced	O
with	O
1	B-Supp
mM	I-Supp
IPTG	I-Supp

genotype	O
/	O
variation	O
:	O
harboring	O
Fnr-8myc	B-Gtype

σ32	O
30°C	B-Temp
rep1	O

genoype	O
:	O
dFNR	B-Gtype

Fur	O
IP	O
ChIP-Seq	B-Technique
Aerobic	B-Air
C	O

culture	O
condition	O
:	O
Anaerobic	B-Air
cultures	O

chip	O
antibody	O
:	O
σ32	B-Anti

chip-Fnr_	O
Fnr8myc	B-Gtype
_	O
glucose	B-Supp
_	O
NH4CL	B-Supp
_	O
NO3	B-Supp
_2	O

genotype	O
:	O
WT	B-Gtype

WT	B-Gtype
glucose	B-Supp
1	O

genoype	O
:	O
Wild-Type	B-Gtype

MG1655	B-Substrain

affyexp_	O
delta-arcA	B-Gtype
_	O
glucose	B-Supp
_	O
NH4CL	B-Supp
_	O
anaerobic	B-Air
_3.CEL	O

CsiR_	O
ChIPSeq	B-Technique

WT	B-Gtype
NaCl	B-Supp
1	O

pT7	O
_	O
ChIPSeq	B-Technique
_1	O

σ32	O
30°C	B-Temp
rep2	O

Δcra	B-Gtype
fructose	B-Supp
2	O

ArgR_	O
Arginine	B-Supp
_1	O

strain	O
:	O
MG1655	B-Orgn

chip-ArcA_	O
ArcA8myc	B-Gtype
_	O
glucose	B-Supp
_	O
NH4CL	B-Supp
_	O
NO3	B-Supp
_2	O

SoxS	O
PQ	B-Supp
2	O

To	O
harvest	O
total	O
RNA	O
samples	O
,	O
overnight	O
cultures	O
of	O
wild	B-Gtype
type	I-Gtype
MG1655	O
grown	O
in	O
LB	O
at	O
37	O
˚C	O
were	O
diluted	O
back	O
1:500	O
in	O
either	O
fresh	O
LB	O
or	O
M63	B-Med
minimal	I-Med
glucose	I-Med
medium	O
and	O
allowed	O
to	O
grow	O
until	O
the	O
cultures	O
reached	O
an	O
OD600	O
of	O
~	O
0.4	O
and	O
2.0	O
for	O
cultures	O
grown	O
in	O
LB	O
and	O
an	O
OD600	B-OD
of	I-OD
~0.4	I-OD
for	O
cultures	O
grown	O
in	O
M63	O
.	O

ChIP-Seq	B-Technique

LB	B-Med
2.0	O
B2	O
TEX	O
pos	O
L2	O
HS2	O

TrpR_	O
glucose	B-Supp

